Gene expression of IQGAPs and Ras families in an experimental mouse model for hepatocellular carcinoma: a mechanistic study of cancer progression by Zoheir, Khairy MA et al.
Int J Clin Exp Pathol 2015;8(8):8821-8831
www.ijcep.com /ISSN:1936-2625/IJCEP0010544
Original Article 
Gene expression of IQGAPs and Ras families  
in an experimental mouse model for hepatocellular  
carcinoma: a mechanistic study of cancer progression
Khairy MA Zoheir1,2, Ahmed A Abd-Rabou3, Gamaleldin I Harisa4,5, Abdelkader E Ashour1, Sheikh Fayaz 
Ahmad1, Sabry M Attia1, Saleh A Bakheet1, Hala E Abdel-Hamied6, Adel R Abd-Allah5, Ashok Kumar7
1Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 
Saudi Arabia; 2Department of Cell Biology, National Research Centre (12622), Cairo, Egypt; 3Department of 
Hormones, Medical Research Division, National Research Centre (12622), Cairo, Egypt; 4Kayyali Chair for 
Pharmaceutical Industry, Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 
2457, Riyadh 11451, Saudi Arabia; 5Departments of Biochemistry and Pharmacology and Toxicology, College of 
Pharmacy (Boys section), Al-Azhar University, Cairo, Egypt; 6Department of Pathology, Faculty of Medicine (Girls), 
Al-Azhar University, Cairo, Egypt; 7Vitiligo Research Chair, College of Medicine, King Saud University, Riyadh, Saudi 
Arabia
Received May 22, 2015; Accepted July 23, 2015; Epub August 1, 2015; Published August 15, 2015 
Abstract: IQGAPs genes play critical role in either induction or suppression of cancer and its progression, however 
the relationship between Ras genes and these genes are still unclear. In this study, we tried to understand the 
mechanistic action of IQGAPs genes and its correlation with Ras genes in mouse hepatic cancer model. The genetic 
expressions of IQGAP1, IQGAP2, IQGAP3, Hras, Kras, Nras, Mras, Caspase3, and BAX were followed in both hepato-
cellular carcinoma and normal liver cells of Balbc mice. Genotoxic agent diethylnitrosamine (DEN)-induced hepatic 
cancer model was induced in male mice and recorded the occurrence of hepatocellular carcinoma by morphological 
and histological changes in the liver. It was observed that mRNA expressions of IQGAP1, Hras, Kras, Nras, Mras, 
Caspase3, and BAX genes were highly elevated in hepatocellular carcinoma cells when compared with normal liver 
cells, additionally their expressions increased by concentrating the dose of DEN. While, the expressions of IQGAP2 
and IQGAP3 were significantly decreased in hepatocellular carcinoma cells when compared with normal liver cells, 
as well as their expressions decreased more with increasing the dose of DEN. It was concluded from this study that 
IQGAP1 has a strong signaling relationship with Ras genes in induction of cancer and it is considered as a key gene 
for induction or suppression of the hepatocellular carcinoma.
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Introduction
Hepatocellular carcinoma (HCC) is responsible 
for between 500,000 and 1 million worldwide 
deaths annually. HCC etiologies are diverse and 
include chronic hepatitis B (HBV) and C (HCV), 
chronic excessive alcohol consumption, steato-
sis, diabetes, and exposure to toxic agents 
such as aflatoxin B1, or any hepatic disease 
associated with cirrhosis [1]. HCC develops 
when there is a mutation in the cellular machin-
ery that causes the cell to divide at a higher 
rate, resulting in the cell to avoid apoptosis [2]. 
Additionally, a number of host factors such as 
male sex, older age at infection, long disease 
duration, excessive alcohol consumption, and 
high liver iron overload have been reported to 
influence disease progression. In particular, 
chronic infections of HBV and/or HCV can aid 
the development of HCC by repeatedly causing 
the body’s own immune system to attack the 
liver cells [3]. HCV infection afflicts more than 
170 million people worldwide, with the great 
majority (~85%) of patients developing chronic 
HCV infection [4]. 
N-nitrosodiethylamine (DEN) is often used as a 
carcinogenic reagent and the target organ in 
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which DEN induces malignant tumors is spe-
cies-specific. Mice mainly develop not only liver 
cancer, but also gastrointestinal [5], skin, respi-
ratory [6], and haematopoietic cancers [7]. The 
carcinogenic capacity of DEN is situated in its 
capability of alkylating DNA structures. DEN 
works in a dose-dependent manner [8]; a single 
low initiation dose not lead to the formation of 
neoplasms, while administration of a high dose 
induces HCC after a period of latency.
Intriguingly, the applications of gene expression 
patterns are well-established that they can 
accurately predict the clinical outcome of HCC 
at the time of diagnosis and therapy. Expression 
of 406 genes was highly correlated with length 
of survival with strong statistical significance. 
The outcome of hierarchical cluster analysis of 
the HCC with the 406 survival genes was simi-
lar to the previous analysis with all the genes 
[9].
Isoleucine-glutamine-motif containing GTPase-
activating proteins (IQGAPs) is a small subgroup 
of evolutionally conserved superfamily of 
GTPase-activating proteins [10]. The IQGAP 
family is found in eukaryotes from yeast to 
mammals and it is named for their isoleucine-
glutamine (IQ) and GTP-activating protein (GAP) 
domains. GAPs play a crucial role in the Ras 
superfamily regulation. Ras proteins act as sig-
nalling switchers by cycling between active 
GTP-bound and inactive GDP-bound states. 
GAPs negatively regulate Ras proteins by cata-
lyzing the switch from the GTP-active to GDP-
inactive state [1]. 
The IQGAP members contain multiple protein-
protein interaction motifs [11]. Intriguingly, the 
IQGAPs regulate distinct cellular processes, 
including cell adhesion and migration as well as 
extracellular signals and cytokinesis. In human 
beings, there are three IQGAPs; IQGAP1, 
IQGAP2, and IQGAP3. IQGAP1 is the best char-
acterized protein of this family and it is ubiqui-
tously expressed, unlike IQGAP2 and IQGAP3, 
in hepatocytes [12]. In addition to four IQ 
domains, IQGAP1 contains a calponin homolo-
gy domain, a polyproline interaction domain, a 
RasGAP-related domain (GRD), and a RasGAP-C 
carboxy-terminal sequence common to IQGAP 
family members [13, 14]. IQGAP1 assists in 
both ERK- and β-catenin-dependent signalling. 
IQGAP1 binds B-Raf, MEK and ERK to facilitate 
their sequential activation and propagation of 
the MAPK cascade [15, 16]. Constitutive acti-
vation of the MAPK pathway is a common onco-
genic trigger in several cancers, notably those 
caused by Ras and B-Raf activating mutations. 
Whilst IQGAP1 possesses a Ras-GRD, it is not 
yet clear whether IQGAP1 binds to Ras. Early 
studies found no detectable binding with Ras 
family members H-Ras or R-Ras [17, 18], but 
positive interaction with active M-Ras. Fur- 
thermore, IQGAP3, not IQGAP1, was recently 
shown to interact with activated H-Ras and 
found to be an upstream regulator of ERK-
dependent proliferative signaling [19]. There- 
fore, IQGAPs may bind to alternate Ras mem-
bers and this selectivity may determine the fate 
of particular Ras-mediated signals.
This study aimed at evaluating the genetic 
expressions of IQGAP family (IQGAP1, IQGAP2, 
and IQGAP3), Ras family (Hras, Kras, Nras, and 
Mras), and apoptotic members (Caspase3 and 
BAX) in DEN-induced mice and normal controls 
to examine the mechanistic action of these 
genes in hepatocellular carcinoma progres- 
sion. 
Materials and methods
Animals
A total of eighty 21-day-old male Balbc mice 
were purchased from the Animal Care Center, 
College of Pharmacy, King Saud University, 
Riyadh, Saudi Arabia and housed in polycar-
bonate cages in an animal facility certified by 
the Association for Assessment and Accredi- 
tation of Laboratory Animal Care. Maintained in 
accordance with the National Institutes of 
Health (NIH) Guide for the Care and Use of 
Laboratory Animals, all of the mice were fed 
NIH-07 diet rodent chow and received water ad 
libitum. The animals were allowed to acclimate 
for a week prior to the experiments.
Chemicals
DEN was purchased from Sigma Chemical, St. 
Louis, MO, USA.  
Experimental design
After acclimation, the 4-week-old mice were 
randomly divided into six experimental groups. 
In the 4-week treatment group, mice were treat-
ed with DEN dissolved in saline by i.p. injection 
at the dosages of 0, 50, and 75 mg/kg on 
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experimental days 0, 7, 14, and 21 (groups 
1-3). In the 8-week treatment group, i.p. injec-
tions were given as above on experimental days 
0, 50 and 75 mg/kg (groups 4-6). At experi-
mental day 233, mice were killed by CO2 
asphyxiation and exsanguinations, weighed, 
and necropsied. The livers were removed in 
toto, weighed, and examined for the presence 
of grossly visible lesions. They were then sepa-
rated by lobe and cut into 1- to 2-mm slices. 
One from each lobe was fixed in formalin for 48 
to 72 hours and then embedded in paraffin to 
give a total of three paraffin blocks per animal. 
Serial sections from each block were stained 
with hematoxylin and eosin (H&E), hepatic pre-
neoplastic and neoplastic lesions were classi-
of liver sections were quantified. Because large 
hepatic tumors were recognized in one animals 
(one animal in the 75 mg/kg for 8 weeks group), 
these areas were not included in the total vol-
ume of liver sections of these animals. The mul-
tiplicity of AHF is reported as numbers per cen-
timeter squared and the volume of foci as the 
percentage of total liver volume (%).
RNA extraction and cDNA synthesis 
Total RNA from the liver tissue homogenate 
was isolated using TRIzol reagent (Invitrogen) 
according to the manufacturer’s instructions 
and quantified by measuring the absorbance at 
260 nm. The RNA quality was determined by 
measuring the 260/280 ratio. 
Table 1. Primer sequences of mouse genes for IQGAPs, Ras, Caspase3, and BAX
NM_001033484.1 Mus musculus IQ motif containing GTPase activating protein 3 (Iqgap3), mRNA F: CCTCCGGAATGGAGTGCTAC
R: CTGCAAGGTGACCAGAGTGT
NM_027711.1 Mus musculus IQ motif containing GTPase activating protein 2 (Iqgap2), mRNA F: GGAAGGGGTTCAAACAACGC
R: TGTCACCATTCGGAACCAGG
NM_016721.2 Mus musculus IQ motif containing GTPase activating protein 1 (Iqgap1), mRNA F: TTCAAGGTCTCTGCGCTTCC
R: GAGGCCGGTAGCCTTGTATC
NM_008624.3 Mus musculus muscle and microspikes RAS (Mras), mRNA F: GGCGCTTTGTTCCGTTCC
R: TATTGTTCCCGCATGGCACT
NM_021284.6 Mus musculus v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (Kras), mRNA F: AGACACGAAACAGGCTCAGG
R: GCATCGTCAACACCCTGTCT
NM_010937.2 Mus musculus neuroblastoma ras oncogene (Nras), mRNA F: GGGGTCTCCAACAGCTTCTC
R: AGGTCTCCTCCAGGGATGTC
NM_008284.2 Mus musculus Harvey rat sarcoma virus oncogene (Hras), transcript variant 1, mRNA F: CTGTCCTGACACCAGGCTC
R: ATGGACCCTCCTGTAGCCAT
NM_009810.3 Mus musculus caspase 3 (Casp3), transcript variant 2, mRNA F: GGGGAGCTTGGAACGCTAAG
R: CCGTACCAGAGCGAGATGAC
NM_007527.3 Mus musculus BCL2-associated X protein (Bax), mRNA F: CTGGATCCAAGACCAGGGTG
R: CCTTTCCCCTTCCCCCATTC
Figure 1. Body and liver weights in Balbc mice.
fied according to the patholo-
gy of the mouse [20].
Quantitative analysis of al-
tered hepatocellular foci
Quantitative analysis of AHF 
was accomplished using a 
two-dimensional evaluation. 
Whole H&E staining sections 
were scanned by ScanScope 
CS. Images were then viewed 
with Aperio’s image viewer 
software (ImageScope), on 
which the quantitative analy-
ses were performed. The 
number and volume of each 
foci (eosinophilic, clear, and 
basophilic) and total volume 
IQGAPs and Ras families in hepatocellular carcinoma
8824 Int J Clin Exp Pathol 2015;8(8):8821-8831
Quantification of mRNA expression by real-
time polymerase chain reaction 
Quantitative analyses of mRNA expressions of 
the target genes which are considered as mark-
weeks 50 mg/kg treatment group (group 2), 
three mice in the 4 weeks 75 mg/kg treatment 
group (group 3), four mice in the 8 weeks 50 
mg/kg treatment group (group 5) and four mice 
in the 8 weeks 75 mg/kg treatment group 
Figure 2. Incidence of histopathological changes of the liver in Balbc mice.
Figure 3. (A, B) The expression of IQGAP genes in liver tissues of different 
treated groups after 4 weeks (A) and 8 weeks (B).
ers for liver fibrosis and injury 
were performed by RT-PCR 
through subjecting the resul-
tant cDNA from the above 
preparation to PCR am- 
plification using 96-well opti-
cal reaction plates in the ABI 
Prism 7500 System (Applied 
Biosystems). The 25 µl reac-
tion mixture contained 0.1 µl 
of 10 µM forward primer and 
0.1 µl of 10 µM reverse primer 
(40 µM final concentration of 
each primer), 12.5 µl of SYBR 
Green Universal Master mix, 
11.05 µl of nuclease-free 
water, and 1.25 µl of cDNA 
sample. The primers used in 
the current study were chos- 
en from pubmed.com (http://
www.ncbi.nlm.nih.gov/tools/
primer-blast) as listed in Table 
1. Assay controls were incor-
porated onto the same plate, 
namely, no-template controls 
to test for the contamination 
of any assay reagents. The 
real-time PCR data have been 
analyzed using the relative 
gene expression (i.e., ÄÄCT) 
method, as described in App- 
lied Biosystems, User Bulletin 
No. 2. Briefly, the data are pre-
sented as the fold change in 
gene expression normalized 
to the endogenous reference 
gene (GAPDH) and relative to 
a calibrator.
Results
General observation, body 
and liver weight
The final body weight and ab- 
solute and relative liver wei- 
ghts are illustrated in Figure 
1. During the experimental 
period, two mice in the 4 
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(group 6) died. The causes of death could not 
be determined at necropsy. Final body weights 
were significantly decreased in the groups 3, 5, 
and 6 as compared with the control group. 
Measurement of organ weight revealed that the 
relative liver weight was significantly increased 
in groups 3 and 6 as compared with the control 
group.
Histopathological examination
Liver morphology of Balbc mice either normal 
or treated by DEN is illustrated in (Figures 2, 6, 
7) summarizes the results of the histopatho-
logical examinations. Hepatocellular adeno-
mas, holangiomas, and hemangiomas were 
observed in group 6. A hepatocellular adenoma 
was also identified in groups 3 and 5. In all DEN 
treatment groups, eosinophilic, clear, and baso-
philic AHF was identified. The incidences of 
clear and basophilic AHF increased in a dose-
dependent manner and were statistically sig-
nificant as compared with control values for 
as shown in (Figures 3-5). Furthermore, their express- 
ions increased by increasing the DEN dose. 
While, the expressions of IQGAP2 and IQGAP3 
genes were significantly lower in all animal 
treated with DEN (P<0.001) compared to those 
of NC group and their expressions decreased 
by increasing the DEN dose as shown in Figure 
3.
Discussion
The development of cellular and molecular bio-
logical techniques, many molecular markers 
related to invasion, metastasis, recurrence, 
and survival have been explored. A large num-
ber of molecular factors have been shown to 
associate with the invasiveness of HCC [21]. 
Another important aspect is the analysis adhe-
sion molecules, proteinases as well as other 
molecules have been regarded as biomarkers 
for the HCC, and are related to prognosis and 
therapeutic outcomes [4]. The cellular changes 
that lead HCC, the etiologic agents responsible 
Figure 4. (A & B) The expression of Ras genes in liver tissues of different 
treated groups after 4 weeks (A) and 8 weeks (B).
groups 2, 3, 5 and 6. Eosi- 
nophilic AHF was also posi-
tively correlated to dose, but 
only those identified in group 
6 were statistically significant. 
In addition, biliary cysts were 
identified in most of the group 
6 animals. 
In the 8-week treatment gr- 
oups, the volume of total foci 
was significantly increased 
from the low-dose group com-
pared with the control group, 
and basophilic AHF account-
ed for more than 50% of the 
total AHF. In the 4-week treat-
ment groups, the volume of 
total foci was significantly 
higher in group 6, and more 
than half of the total AHF was 
basophilic. 
Gene expression level
The genetic expressions of 
IQGAP1, raps (H, K, N and M), 
Caspase 3, and BAX were sig-
nificantly higher in DEN-indu- 
ced cancer group compared 
to normal control (NC) group 
IQGAPs and Ras families in hepatocellular carcinoma
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for the majority of HCC and the molecular 
pathogenesis of HCC is not well understood 
[22]. Despite considerable progress in using 
clinical and pathologic diagnosis of HCC to pre-
dict patient survival and responses to therapy, 
a number of issues remain unresolved.
With few exceptions, cluster memberships of 
each tumor remained the same in the hierarchi-
cal cluster dendrograms, highlighting again the 
robustness of the predicted HCC subclasses 
and their association with the length of survival 
[9].
To disclose detailed genetic mechanisms in 
HCC with a view toward development of novel 
therapeutic targets, Wang et al. [23] make 
identification and validation of a novel gene 
associated with the recurrence of human HCC. 
Also, Hiroshi et al. [24] analyzed expression 
profiles of 20 primary HCCs and their corre-
sponding noncancerous tissues by means of 
cDNA microarrays. Up-regulation of mitosis-
promoting genes was observed in the majority 
of the tumors examined. Some genes showed 
constitutive activation of p21.sup.ras. Ex- 
pression of abnormally high levels of normal 
p21.sup.ras as a result of gene amplification or 
regulatory sequence mutations may also con-
tribute to the transformation of normal cells to 
cancerous cells [26].
The ras genes which encode 21 kDa proteins 
are expressed ubiquitously and are found asso-
ciated with the plasma membrane in the cyto-
plasm of the cell. p21.sup.ras is a guanine 
nucleotide-binding protein which catalyzes the 
hydrolysis of bound guanine triphosphate (GTP) 
to guanine diphosphate (GDP) and is believed 
to be a key component of a complex intracellu-
lar signal transduction pathway from the plas-
ma membrane to the nucleus. It is active when 
bound to GTP and inactive in its GDP-bound 
state [25, 26].
The current study deduced that the genetic pro-
file of IQGAP1, ras (H, K, N and M), caspase 3, 
and BAX were higher in DEN-induced cancer 
group compared to normal control (NC) group. 
Figure 5. (A & B) The expression of Casp3 and BAX genes in liver tissues of 
different treated groups after 4 weeks (A) and 8 weeks (B).
expression patterns in hepati-
tis B virus-positive HCCs that 
were different from those in 
hepatitis C virus-positive 
HCCs; most of them encoded 
enzymes that metabolize car-
cinogens and/or anticancer 
agents [22]. Furthermore, 
they identified a number of 
genes associated with malig-
nant histological type or inva-
sive phenotype. Accumulation 
of such data will make it pos-
sible to define the nature of 
individual tumors, to provide 
clues for identifying new ther-
apeutic targets, and ultimate-
ly to optimize treatment of 
each patient [24].
The mechanisms of tumori-
genesis in vivo and in vitro are 
poorly understood. Overwhel- 
ming evidence indicates that 
specific mutated forms of the 
p21.sup.ras gene (ras) con-
tribute to tumorigenesis [25]. 
When analyzed in a variety of 
neoplasms, the ras genes fre-
quently contain characteristic 
point mutations that result in 
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While, the expressions of IQGAP2 and IQGAP3 
genes were lower in all DEN-induced animal 
models compared to those of NC group. These 
observations agreed with previous studies indi-
cated that the ras gene is the most frequently 
identified oncogene in human cancer, but onco-
genic p21.sup.ras is resistant to the action of 
known mammalian ras-GAPs [27, 28]. 
There is mounting evidence to suggest a role 
for IQGAP1 in cancer progression. The many 
cellular processes that IQGAP1 orchestrates 
are highly relevant to cancer. IQGAP1 protein is 
not mutated but does display an unusually high 
expression in several cancer types, correlating 
with poor outcome [29].
Additionally, Colin et al. [21] have reviewed pub-
lished data which implicate IQGAPs in cancer 
and tumorigenesis where the cumulative evi-
dence suggests IQGAP1 is an oncogene while 
IQGAP2 may be a tumor suppressor. Colin et al. 
[21] discussed evidence derived from human 
neoplasms and mouse models of cancer, which 
more directly identify the involvement of 
IQGAP1 and IQGAP2 in neoplastic transforma-
tion and metastasis. The inverse correlation of 
IQGAP1expression with cancer progression 
suggests that IQGAP2 may be a tumor suppres-
sor. This hypothesis was supported by studies 
which showed reduced expression of the 
IQGAP1 gene in hormone-refractory prostate 
cancer and. However, other reports contradict 
these findings as they observe overexpression 
of IQGAP1 in tissue from cancers of the colon 
and prostate [29]. Thus, while there is evidence 
to suggest that IQGAP2 acts as a tumor sup-
pressor, more thorough investigations are 
required in order to verify this postulate and 
ascertain whether it pertains only to selected 
neoplasms.
In yet another aspect, the invention features a 
method of detecting a neoplastic cell in a tis-
sue. The method involves measuring IQGAPs 
expression wherein decreased or increased 
expression of these genes product compared 
to a standard or known level of expression 
associated with normal tissue is indicative of 
the presence of a neoplastic cell. IQ-domain 
GTPase-activating proteins (IQGAPs) are an 
evolutionary conserved family of multi-domain 
proteins. These proteins regulate distinct cellu-
lar processes including cell adhesion, cell 
migration, extracellular signals and cytokines 
[3]. 
The name IQGAP1 is derived from two of its 
many interacting domains: four centrally locat-
ed IQ motifs and a C-terminal Ras-GAP-related 
Figure 6. Morphology of Balbc mice liver treated by DEN (A) is normal control and (B) is treated by 75 mg/kg DEN 
8 weeks.
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domain. Traditional GTPase-activating proteins 
(GAPs) are regulatory effectors of GTPases 
such as those of the Ras superfamily. Ras pro-
teins act as signalling switches by cycling 
Figure 7. Formation of altered hepatocellular foci (AHF) and tumors in the liver of Balbc mice treated with diethylni-
trosamine. (A-D) The lesions of a hepatocellular adenoma (C and D), a cholangioma (D), and a hemangioma (C-F). 
(H) Typical basophilic, clear, and eosinophilic AHF, along with a biliary cyst. (A and B) Hematoxylin and eosin stained. 
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between active GTP-bound and inactive GDP-
bound states. GAPs negatively regulate Ras 
proteins by catalyzing the switch from the GTP-
active to GDP-inactive state [21]. 
IQGAP1, however, does not act as a traditional 
GAP and is able to stabilize small Rho GTPases 
Rac1 and Cdc42 in the GTP-bound state [19]. 
IQGAP1 activity itself is controlled by the ubiq-
uitous calcium-binding protein, calmodulin, via 
the IQ motifs-classical calmodulin-interacting 
domains found in numerous proteins. It was 
hypothesized that calmodulin alters IQGAP1 
activity by inducing a conformational change 
which influences IQGAP1-protein interactions 
and/or the subcellular localization of IQGAP1 
[30]. IQGAP1 also possesses a calponin-homol-
ogy domain (CHD) that binds F-actin, putative 
coil-coil homodimerisation domains, a trypto-
phan repeat motif (WW) of undefined function 
and a RasGAP_C-terminus (RGCt) that binds 
numerous proteins including APC, E-cadherin 
and β-catenin. The broad range of interacting 
partners places IQGAP1 as a key mediator of 
numerous cellular processes and signalling 
pathways [21]. 
IQGAP1 is a member of a three-isoform family 
of proteins that also includes IQGAP2 [31] and 
IQGAP3 [23]. IQGAP1, the most studied, binds 
calmodulin, cross-links actin filaments, inte-
grates signaling networks [12], and regulates 
cell-cell contacts and the capture of microtu-
bule plus-ends via association with CLIP-170 
[30].
Eric et al. [32] presented a novel role for IQGAP1 
in the regulation of exocytosis, where they in- 
vestigated whether mammalian IQGAP1 asso-
ciates with the exocyst-septin complex and 
influences secretion in a CDC42-regulated fash-
ion. They found that overexpression or activa-
tion of CDC42 by mastoparan; dominant-active 
mutations or IQGAP1 expression disrupted the 
endogenous association of IQGAP1 with the 
exocyst-septin complex and blocked secretion. 
This effect appeared to be mediated by the 
C-terminus of IQGAP1, which binds CDC42 and 
inhibits secretion [21].
By contrast, the N-terminus of IQGAP1 binds to 
the exocyst-septin complex, enhances secre-
tion and abrogates the inhibition caused by 
CDC42 or the depletion of IQGAP1, perhaps via 
the involvement of the N-terminus in protein 
synthesis, as indicated by pulse-chase experi-
ments. These data raised a possibility that 
IQGAP1 serves as a regulator of secretion by 
acting as a conformational switch [32]. The 
level of expression of IQGAP genes and mRNAs 
are frequently altered in neoplasia. IQGAP1 has 
been proposed to be an oncogene. Consistent 
with this postulate, comparison of the genetic 
profiles of tumors with those of normal tissue, 
and comparison of more aggressive cancers 
with less aggressive neoplasms, reveals that 
the IQGAP1 gene and/or mRNA are overex-
pressed in all analyses reported. Increased 
expression of IQGAP1 has been observed in 
several human neoplasms, including lung, co- 
lorectal cancers and oligodendroglioma. Ana- 
logous observations have been reported in 
mouse models [21]. IQGAP1 gene was ampli-
fied in HSC39 and HSC40A gastric cancer cell 
lines. This amplification corresponded to an 
increase in both IQGAP1 mRNA and protein, 
compared with normal gastric cell lines, and an 
accumulation of IQGAP1 protein at the cell 
membrane [3].
IQGAP2 had also generated several “hits” in 
genetic screens comparing normal with neo-
plastic tissue. The results, however, were less 
unequivocal than those for IQGAP1. IQGAP2 
expression was lost from 5/9 gastric cancer 
cell lines due to aberrant methylation of the 
IQGAP2 promoter [3].
Constitutive activation of the MAPK pathway is 
a common oncogenic trigger in several can-
cers, notably those caused by Ras and B-Raf 
activating mutations. Whilst IQGAP1 possess-
es a Ras-GRD, it is not yet clear whether IQGAP1 
binds to Ras. Early studies found no detectable 
binding with Ras family members H-Ras or 
R-Ras [17] but positive interaction with active 
M-Ras [18]. Furthermore, IQGAP3, not IQGAP1, 
was recently shown to interact with activated 
H-Ras and found to be an upstream regulator of 
ERK-dependent proliferative signaling [19]. 
Therefore, IQGAPs may bind to alternate Ras 
members and this selectivity may determine 
the fate of particular Ras-mediated signals.
Finally, it was concluded that IQGAP1 has a 
strong signaling network with Ras (H, K, N and 
M) genes in induction of cancer. In addition, 
IQGAP/Ras signaling pathway may be consid-
ered as a key for induction or suppression of 
the HCC.
IQGAPs and Ras families in hepatocellular carcinoma
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